Search

The Peter O’Donnell Jr. Brain Institute is guided by the expertise of talented leaders across several disciplines at UT Southwestern.

Wanda began seeing doctors at UT Southwestern, where they started her on a new drug called Repatha. Based on a discovery made by UT Southwestern, Repatha is a cholesterol-lowering drug for statin intolerant patients like Wanda. She saw an immediate and dramatic improvement in her cholesterol numbers

The power of genetic testing to aid in cancer prevention is amplified with cascade testing.

Leveraging chIA-PET sequencing, researchers at UT Southwestern have discovered findings that could lead to novel prostate cancer therapies. Learn more here.

At #AHA22, UT Southwestern's James de Lemos, M.D., presented results from an ambulatory blood pressure monitoring substudy of the SURMOUNT-1 trial.

Researchers at UT Southwestern are studying the impact of the standardization of care and access to specialized professionals across populations. Here’s the results.

At #AHA22, UT Southwestern cardiologists presented an analysis from the iSCAD Registry that focused on diagnostic delays among SCAD patients.

After contracting acute flaccid myelitis in October 2016, Sarah woke up in the ICU paralyzed, unable to even breathe on her own.

The holidays are a time of love and cheer, but can be difficult for families of cancer patients. These tips can make talking about treatment a bit easier.

People with cancer find hope in many ways. It may be through the support of family members, or it may be through a new treatment. For Chuck Dandridge, the two were intertwined in a way he could’ve never imagined.